TNFSF13 Protein (AA 16-108, AA 88-233) (DYKDDDDK Tag)

Produktnummer ABIN1344412

Recombinant TNFSF13-Protein exprimiert in HEK-293 Cells und wurde in 9+ Publikationen erwähnt.

Kurzübersicht für TNFSF13 Protein (AA 16-108, AA 88-233) (DYKDDDDK Tag) (ABIN1344412)

Target: TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

Protein-Typ: Recombinant

Biologische Aktivität: Active

Spezies: Human, Maus

Quelle: HEK-293 Cells

Applikation: SDS-PAGE (SDS)

Reinheit: >95 % (SDS-PAGE)

Produktdetails

Proteineigenschaft: AA 16-108, AA 88-233

Aufreinigungstag / Konjugat: Dieses TNFSF13 Protein ist gelabelt mit DYKDDDDK Tag.

Verwendungszweck: APRIL (human) (multimeric) (rec.)

Marke: MegaAPRIL™

Spezifität: Binds to human and mouse BCMA and TACI. Binds to proteoglycans.

Kreuzreaktivität: Human, Maus

Produktmerkmale: The extracellular domain of human APRIL (aa 88-233) is fused at the N-terminus to human ACRP30headless (aa 16-108) and a FLAG®-tag.

Endotoxin-Niveau: <0.01EU/μg purified protein (LAL test).

Biological Activity Comment: Stimulates B cell proliferation.

Anwendungsinformationen

Applikationshinweise: Optimal working dilution should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: 0.1 mg/mL

Buffer: Contains PBS.

Handhabung: After reconstitution, prepare aliquots and store at -20 °C. Avoid freeze/thaw cycles. Centrifuge lyophilized vial before opening and reconstitution. PBS containing at least 0.1 % BSA should be used for further dilutions.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung:

Short Term Storage: +4°C

Long Term Storage: -20°C

Use & Stability: Stable for at least 6 months after receipt when stored at -20°C. Working aliquots are stable for up to 3 months when stored at -20°C.

Haltbarkeit: 6 months

Referenzen

Rodríguez-Bayona, Ramos-Amaya, López-Blanco, Campos-Caro, Brieva: "STAT-3 activation by differential cytokines is critical for human in vivo-generated plasma cell survival and Ig secretion." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 191, Issue 10, pp. 4996-5004, (2013) (PubMed).

Sakurai, Hase, Kanno, Kojima, Okumura, Kobata: "TACI regulates IgA production by APRIL in collaboration with HSPG." in: Blood, Vol. 109, Issue 7, pp. 2961-7, (2007) (PubMed).

Endo, Nishio, Enzler, Cottam, Fukuda, James, Karin, Kipps: "BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-kappaB pathway." in: Blood, Vol. 109, Issue 2, pp. 703-10, (2007) (PubMed).

Mongini, Inman, Han, Fattah, Abramson, Attur: "APRIL and BAFF promote increased viability of replicating human B2 cells via mechanism involving cyclooxygenase 2." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 176, Issue 11, pp. 6736-51, (2006) (PubMed).

Craxton, Draves, Gruppi, Clark: "BAFF regulates B cell survival by downregulating the BH3-only family member Bim via the ERK pathway." in: The Journal of experimental medicine, Vol. 202, Issue 10, pp. 1363-74, (2005) (PubMed).

Bonci, Hahne, Felli, Peschle, De Maria: "Potential role of APRIL as autocrine growth factor for megakaryocytopoiesis." in: Blood, Vol. 104, Issue 10, pp. 3169-72, (2004) (PubMed).

He, Chadburn, Jou, Schattner, Knowles, Cerutti: "Lymphoma B cells evade apoptosis through the TNF family members BAFF/BLyS and APRIL." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 172, Issue 5, pp. 3268-79, (2004) (PubMed).

Litinskiy, Nardelli, Hilbert, He, Schaffer, Casali, Cerutti: "DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL." in: Nature immunology, Vol. 3, Issue 9, pp. 822-9, (2002) (PubMed).

Stein, López-Fraga, Elustondo, Carvalho-Pinto, Rodríguez, Gómez-Caro, De Jong, Martínez-A, Medema, Hahne: "APRIL modulates B and T cell immunity." in: The Journal of clinical investigation, Vol. 109, Issue 12, pp. 1587-98, (2002) (PubMed).

Antigendetails

Target: TNFSF13 (Tumor Necrosis Factor (Ligand) Superfamily, Member 13 (TNFSF13))

Andere Bezeichnung: APRIL

Hintergrund:

MultimericAPRIL™, ACRP30headless:APRIL, ACRP30headless:CD256, ACRP30headless:TNFSF13, ACRP30headless:A-proliferation-inducing Ligand:

APRIL is a cytokine that belongs to the TNF superfamily and binds to TACI and BCMA. It is implicated in the regulation of tumor cell growth, is involved in monocyte/macrophage-mediated immunological processes and functions as an important survival factor for plasmablasts and bone marrow plasma cells. MultimericAPRIL™ is a high activity construct in which two trimeric APRIL ligands are artificially linked via the collagen domain of ACRP30. This construct very effectively stimulates proliferation B cell. A basic amino acid sequence (QKQKKQ) close to the NH2 terminus of APRIL is required for binding to negatively charged sulfated glycosaminoglycan side chains of proteoglycans. Proteoglycans mediate binding of APRIL to tumor cells as well as primary lymphoid cells.

Molekulargewicht: ~36kDa (SDS-PAGE)

UniProt: O75888

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response